Analyst Ratings for Ionis Pharmaceuticals (IONS) [Sells]

IONS Rating Summary

IONS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IONS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $59.04 (+61.6%) * Over Last 12-Mos
Rating Score: 4 / 10   Percentile Rank: 37%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/7/2019 Morgan Stanley
» Updated 5/6/2021
David Lebowitz Downgrade Underweight
(Equalweight)
35.00
(38.00)
54.39
(36.54)
-32.82% Details
10/6/2017 Goldman Sachs
» Updated 8/28/2018
Salveen Richter New Coverage Sell
(N/A)
36.00
(N/A)
56.01
(36.54)
-34.76% Details
Like IONS Ratings? Also take a look at AKCA, BIIB, ACCD, PFE

IONS Ratings News